The optimal use of combination therapy with peginterferon and nucleoside analogues to achieve the best outcomes in patients with chronic hepatitis B has been clarified in new studies "Together these ground-breaking data will go a long way to influencing future CHB treatment guidelines," said EASL's Educational Councillor Professor Cihan Yurdaydin from the Department of Gastroenterology, University of Ankara, Turkey. In the first study , CHB patients ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment